ISSN: 0973-7510

E-ISSN: 2581-690X

Mohammad Ali Mobasher1,2, Younes Ghasemi1,2 , Nima Montazeri-Najafabady1,2, Abdollah Ghasemian1,2, Sara Rasoul-Amini1,2,3, Shiva Hemmati1,2 and Sirus Ebrahimi4
1Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 71345 1583, Shiraz, Fars, Iran.
2Department of Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 71345 1583, Shiraz, Fars, Iran.
3Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 71345 1583, Shiraz, Fars, Iran.
4Department of Chemical Engineering, Sahand University of Technology, P.O. Box 53317 11111, Tabriz, Iran.
J Pure Appl Microbiol. 2013;7(4):2867-2871
© The Author(s). 2013
Received: 21/01/2013 | Accepted: 25/02/2013 | Published: 30/12/2013
Abstract

Interferons are a large group of biological substances with many important functions like immunomodulatory, antiviral and anti inflammatory activities. There are so many clinical applications for IFN b for example in treatment of multiple sclerosis (MS), hepatitis, genital condylomata acuminate and arthritis. In this study the optimized IFN b 1b for expression in E.coli BL21 was designed and coloned in pET15b. In general, because of its toxicity and instability the yield of expressed IFN b 1b is low, so the amounts of expression and the effect of co products on production of IFN b 1b were evaluated and a two step production condition was designed for more efficacy in expression of this important biological recombinant product.

Keywords

Interferon, Optimization, cloning, Multiple sclerosis, E. coli

Article Metrics

Article View: 816

Share This Article

© The Author(s) 2013. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.